Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CTC-EXPRESS: A Prospective Observational Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer

NCT06833853 is registered in ClinicalTrials.gov with Menarini Silicon Biosystems, INC as lead sponsor.

NCT NCT06833853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06833853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CTC-EXPRESS: A Prospective Observational Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer
Lead sponsor
Menarini Silicon Biosystems, INC
Phase
Observational
Overall status
Recruiting
Start date
March 13, 2026
Completion date
October 31, 2028
Enrollment
187 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer (mbc)